Search clinical trials for: dalfampridine
Total 38 results
-
John ElfarNot yet recruitingWounds and Injuries | Wound Heal | Wounds | Wound of SkinUnited States
-
UCB Biopharma SRLNot yet recruitingGeneralized Myasthenia Gravis
-
MGH Institute of Health ProfessionsNot yet recruitingMultiple SclerosisUnited States
-
Ain Shams UniversityRecruiting
-
Shirley Ryan AbilityLabNational Institute of Neurological Disorders and Stroke (NINDS)Recruiting
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
D'Youville CollegeUniversity at Buffalo; Acorda TherapeuticsCompleted
-
European University of LefkeCompletedHereditary Spastic ParaplegiaCyprus
-
Milton S. Hershey Medical CenterTerminatedNerve InjuryUnited States
-
State University of New York at BuffaloCompleted
-
VA Office of Research and DevelopmentCompletedMultiple Sclerosis | Fatigue | Internuclear OphthalmoplegiaUnited States
-
Washington University School of MedicineAcorda TherapeuticsCompleted
-
BiogenCompletedMultiple SclerosisFrance, Spain, Germany, Netherlands, Argentina, Czechia, Israel, Portugal, United Arab Emirates, Canada, Norway, Lebanon, Ireland
-
Acorda TherapeuticsTerminatedPost-ischemic StrokeUnited States, Canada
-
Brown, Theodore R., M.D., MPHAcorda TherapeuticsCompletedMultiple SclerosisUnited States
-
Acorda TherapeuticsCompletedPost-Ischemic StrokeUnited States, Canada
-
Johns Hopkins UniversityAcorda TherapeuticsCompletedNeuromyelitis Optica | Transverse Myelitis | Idiopathic Transverse Myelitis | Myelitis NOSUnited States
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation... and other collaboratorsCompletedSpinal Cord InjuryUnited States
-
Brigham and Women's HospitalCompletedSleep Apnea, ObstructiveUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Finland, Italy, United Kingdom, Bulgaria, Serbia, Russian Federation, Lithuania, Poland, Czech Republic, Netherlands
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
BiogenCompletedMultiple SclerosisFrance, Italy, United Kingdom, Germany, Australia, Belgium, Netherlands, Portugal, Denmark
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
Columbia UniversityCompletedSpinal Muscular AtrophyUnited States
-
Neuro-Ophthalmologic Associates, PCAcorda TherapeuticsCompletedNon Arteritic Ischemic Optic NeuropathyUnited States
-
Acorda TherapeuticsCompletedIschemic StrokeUnited States
-
University of ZurichUnknown
-
Mount Sinai Rehabilitation HospitalBrown University; Acorda TherapeuticsCompletedMultiple SclerosisUnited States
-
University of FloridaAcorda TherapeuticsCompletedSpinocerebellar Ataxias Type 1 | Spinocerebellar Ataxias Type 2 | Spinocerebellar Ataxias Type 3 | Spinocerebellar Ataxias Type 6United States
-
Sheba Medical CenterUnknown
-
BiogenAcorda TherapeuticsCompleted
-
BiogenAcorda TherapeuticsCompleted
-
Acorda TherapeuticsCompletedCerebral Palsy (CP)United States
-
Oregon Health and Science UniversityAcorda TherapeuticsCompleted
-
Acorda TherapeuticsPrometrika, LLC; BCS Consulting, Inc.Completed
-
Acorda TherapeuticsCompleted
-
Acorda TherapeuticsCompletedRenal InsufficiencyUnited States